Hypertension may increase risk for developing glaucoma
the ONA take:
According to a new study published in the journal Investigative Ophthalmology and Visual Science, chronic hypertension may increase a person's risk for developing glaucoma.
For the study, researchers from the department of optometry and vision sciences at the University of Melbourne in Melbourne, Australia, raised the blood pressure of rats either for 1 hour (short-term hypertension) or for 4 weeks (long-term hypertension).
When the researchers raised the blood pressure for just 1 hour, eye pressure did not increase, but when their blood pressures were elevated for 4 weeks, the researchers found an increase in eye pressure, suggesting that chronic hypertension increases the risk of glaucoma.
It had previously been thought that hypertension counteracts the eye pressure elevation that ultimately causes glaucoma, but this research indicates that chronic hypertension might damage the ophthalmic blood vessels so that the blood vessels cannot compensate for blood flow changes caused by eye pressure elevation.
The researchers note that further research is warranted to better understand the best approach to treat patients with hypertension who also develop glaucoma, but now, clinicians should regard hypertension as a risk factor for glaucoma.
Chronic hypertension may increase a person's risk for developing glaucoma.
- Sexual Dysfunction in Women With Cancer: A Review of Available Interventions
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
- Lenalidomide After ASCT Prolongs Time to Progression in Multiple Myeloma
- Arthritis Medication Shows Potential in the Treatment of Polycythemia Vera
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|